Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corporation    EW

EDWARDS LIFESCIENCES CORPORATION (EW)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/12/2018 10/15/2018 10/16/2018 10/17/2018 10/18/2018 Date
143.39(c) 141.79(c) 147.02(c) 148.63(c) 147.32 Last
2 118 624 2 009 187 1 812 069 1 363 556 1 754 539 Volume
+2.59% -1.12% +3.69% +1.10% -0.88% Change
More quotes
Financials (USD)
Sales 2018 3 831 M
EBIT 2018 1 157 M
Net income 2018 965 M
Finance 2018 472 M
Yield 2018 -
Sales 2019 4 235 M
EBIT 2019 1 321 M
Net income 2019 1 105 M
Finance 2019 1 083 M
Yield 2019 -
P/E ratio 2018 32,30
P/E ratio 2019 28,67
EV / Sales2018 8,00x
EV / Sales2019 7,09x
Capitalization 31 121 M
More Financials
Company
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring.It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World.Its products are categorized into three areas: Surgical Heart... 
More about the company
Surperformance© ratings of Edwards Lifesciences Corpo
Trading Rating : Investor Rating :
More Ratings
Latest news on EDWARDS LIFESCIENCES CORPO
03:15pEDWARDS LIFESCIENCES CORP : quaterly earnings release
10/09EDWARDS LIFESCIENCES : To Host Earnings Conference Call On October 23, 2018
PR
10/08EDWARDS LIFESCIENCES : Announces Start Of U.S. Study Of Self-Expanding Transcath..
PR
10/06EDWARDS LIFESCIENCES : U.S. firm Edwards Lifesciences to open facility in Limeri..
AQ
09/26EDWARDS LIFESCIENCES' : Philanthropy Exceeds Every Heartbeat Matters Goal To Imp..
PU
09/14EDWARDS LIFESCIENCES CORPORATION : Report
CO
09/12EDWARDS LIFESCIENCES CORPORATION : Report
CO
09/05EDWARDS LIFESCIENCES CORPORATION : Report
CO
08/31EDWARDS LIFESCIENCES CORPORATION : Report
CO
08/30EDWARDS LIFESCIENCES : To Present At The 13th Annual Wells Fargo Healthcare Conf..
PR
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12:36pDANAHER : Raises Guidance on Rising Profits
DJ
10/06THERMO FISHER SCIENTIFIC : Electron CEO Dived Into Economics
DJ
10/02European shares retreat as Italy, Brexit fears weigh
RE
10/02For First Time, GE Turns to an Outsider -- WSJ
DJ
10/02GE Ousts John Flannery as CEO After Missed Targets--9th Update
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
MarketScreener Strategies on EDWARDS LIFESCIENCES CORPO 
EDWARDS LIFESCIENCES - 2016
Still a great upward potential
BUY
EDWARDS LIFESCIENCES  - 2015
Trading opportunity
BUY
More Strategies
Latest Tweets
11:20aEdwards Lifesciences Corp $EW VP Catherine M. Szyman Sells 700 Shares  
10/16ONLY IN... GEORGIA? An airport security K9 found a cooked pig's head inside s..
5
10/16On The Fly: Top five analyst initiations $ABT $BSX $SYK $MDT $BAX $EW $ZBH $E..
1
10/16Tuesday's top analyst upgrades and downgrades PART 1 $ABT $ADBE $BAC $BAX $BS..
1
10/12Brokerages Set Edwards Lifesciences Corp $EW Target Price at $154.16  
More tweets
Qtime:79
News from SeekingAlpha
10/17WEDGEWOOD PARTNERS Q3 2018 CLIENT LE : Anatomy Of A Bull Market 
10/16Premarket analyst action - healthcare 
10/15INTRODUCING THE OPTIONS TRADER : Trade Options On U.S. Equities 
10/09Invesco S&P 500 Equal Weight ETF (RSP) September Summary 
10/09Vail Resorts Is A Long-Term Buy - Cramer's Lightning Round (10/8/18) 
Chart EDWARDS LIFESCIENCES CORPORATION
Duration : Period :
Edwards Lifesciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EDWARDS LIFESCIENCES CORPO
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 161 $
Spread / Average Target 8,5%
EPS Revisions
Managers
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Stanton J. Rowe Chief Scientific Officer & VP-Advanced Technology
John P. McGrath Vice President-Quality, Regulatory & Clinical
William J. Link Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES CORPORATION25.80%31 121
THERMO FISHER SCIENTIFIC21.87%94 516
DANAHER CORPORATION9.88%73 446
INTUITIVE SURGICAL42.29%61 755
BOSTON SCIENTIFIC CORPORATION46.95%52 551
ILLUMINA47.23%48 357